mRNA Cancer Vaccines And Therapeutics Global Market Report 2025

Global mRNA Cancer Vaccines And Therapeutics Market Report 2025

mRNA Cancer Vaccines And Therapeutics Global Market Report 2025 – By Type (Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas), By Application (Infectious Disease, Cancer, Other Applications), By End User (Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: mRNA Cancer Vaccines And Therapeutics Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

mRNA Cancer Vaccines And Therapeutics Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

mRNA Cancer Vaccines And Therapeutics Global Market Report 2025

Proud Members Of

mRNA Cancer Vaccines And Therapeutics Market Definition

mRNA cancer vaccines and therapeutics refer to a type of medical treatment that utilizes messenger RNA (mRNA) to stimulate the immune system to recognize and fight cancer cells. It is used to deliver instructions to cells to produce therapeutic proteins or enzymes and help prime the immune system to identify and destroy cancer cells that express these antigens.

The main mRNA cancer vaccines and therapeutics types are adeno carcinomas, mucinous carcinomas, and adenosquamous carcinomas. Adeno carcinomas refers to a type of cancer that forms in mucus-secreting glands throughout the body. It is applied for infectious disease, cancer, and others and IT is used by several end users such as hospitals and clinics, ambulatory surgical centers, research institutes, and others.

mRNA Cancer Vaccines And Therapeutics Market Segmentation

The mRNA cancer vaccines and therapeutics market covered in this report is segmented –

1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

2) By Application: Infectious Disease, Cancer, Other Applications

3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Subsegments:

1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas

2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer

3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma

mRNA Cancer Vaccines And Therapeutics Market Size and growth rate 2025 to 2029: Graph

mRNA Cancer Vaccines And Therapeutics Market Size 2025 And Growth Rate

The mRNA cancer vaccines and therapeutics market size has grown rapidly in recent years. It will grow from $61.52 billion in 2024 to $71.85 billion in 2025 at a compound annual growth rate (CAGR) of 16.8%. The growth in the historic period can be attributed to the shifting lifestyles, the funding support, the favorable regulatory environment, the well-established healthcare infrastructure, and increasing pipeline development.

mRNA Cancer Vaccines And Therapeutics Market Growth Forecast

The mRNA cancer vaccines and therapeutics market size is expected to see rapid growth in the next few years. It will grow to $131.99 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to promising clinical trial results, growing awareness and acceptance of mRNA technology, unmet medical needs in cancer treatment, potential for improved patient outcomes and potential for off-the-shelf availability. Major trends in the forecast period include expansion into new therapeutic areas, personalized medicine approach, advancements in mRNA delivery systems, multivalent mRNA Vaccines and artificial intelligence and machine learning in mRNA design.

Book your 30 minutes free consultation with our research experts

mRNA Cancer Vaccines And Therapeutics Market Driver: Surge In Cancer Prevalence Boosts mRNA Vaccine And Therapeutics Market Growth

The rise in the prevalence of cancer is expected to propel the growth of the mRNA cancer vaccine and therapeutic market going forward. Cancer is a broad term for a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, that invade and destroy normal body tissue. The rise in the prevalence of cancer is due to sedentary lifestyles, unhealthy eating habits, and exposure to environmental toxins. mRNA cancer vaccines and therapeutics are required for cancer because they offer personalized, targeted treatments that can enhance the immune system's ability to recognize and attack cancer cells, improving treatment efficacy and patient outcomes. For instance, in January 2023, according to the data published by the American Cancer Society, a US-based non-profit organization working to eliminate cancer, the estimated number of new cancer cases in the United States, was around 1,918,030 in 2022, which increased to 1,958,310 in 2023. Breast cancer is the leading chronic condition in the United States, increasing from 287,850 cases in 2022 to 297,790 cases in 2023, respectively. Therefore, the rise in the prevalence of cancer is driving the growth of the mRNA cancer vaccine and therapeutics market.

Global mRNA Cancer Vaccines And Therapeutics Market Major Players

Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.

Global mRNA Cancer Vaccines And Therapeutics Market Trend: FDA Approves WGc-043, Boosting Innovations In mRNA Cancer Vaccines And Therapies

Major players operating in the mRNA cancer vaccine and therapeutics market are focused on the development of innovative treatments such as mRNA cancer vaccines to enhance efficacy, improve patient outcomes, and address the growing demand for effective cancer therapies. mRNA cancer vaccines are a type of immunotherapy that use messenger RNA to instruct cells to produce specific antigens, thereby stimulating the immune system to recognize and attack cancer cells. For instance, in May 2024, WestGene Biopharma, a China-based, biotechnology company received FDA approval for an investigational new drug application of its mRNA therapeutic cancer vaccine, WGc-043. The FDA approval of WGc-043 marks a breakthrough in treating advanced EB virus-related cancers, which are strongly linked to over ten malignancies, including nasopharyngeal carcinoma, NK T-cell lymphoma, and gastric, lung, liver, esophageal, breast, and cervical cancers, as well as autoimmune diseases such as multiple sclerosis and lupus.

mRNA Cancer Vaccines And Therapeutics Market Merger And Acquisition: CureVac Acquires Frame Cancer Therapeutics to Strengthen Oncology Strategy

In June 2022, CureVac N.V., a Germany-based biopharmaceutical company, acquired Frame Cancer Therapeutics for approximately $34.19 million (€32 million). The acquisition aims to accelerate CureVac's oncology strategy by incorporating Frame Cancer Therapeutics' novel antigen discovery platform. This will strengthen CureVac’s ability to identify and validate promising neoantigens for the development of mRNA-based cancer vaccines. Frame Cancer Therapeutics is a Netherlands-based company that specializes in providing mRNA cancer vaccine and therapeutics.

Regional Outlook For The Global mRNA Cancer Vaccines And Therapeutics Market

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mRNA cancer vaccines and therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the mRNA Cancer Vaccines And Therapeutics Market?

mRNA cancer vaccines and therapeutics market consists of sales of individualized cancer treatment mRNA vaccine, infectious disease treatment mRNA vaccine, and infection prevention mRNA vaccine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the mRNA Cancer Vaccines And Therapeutics Industry?

The mRNA market research report is one of a series of new reports from The Business Research Company that provides mRNA market statistics, including mRNA industry global market size, regional shares, competitors with a mRNA market share, detailed mRNA market segments, market trends and opportunities, and any further data you may need to thrive in the mRNA industry. This mRNA market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

mRNA Cancer Vaccines And Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$71.85 billion
Revenue Forecast In 2034	$131.99 billion
Growth Rate	CAGR of 16.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas 2) By Application: Infectious Disease, Cancer, Other Applications 3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users Subsegments: 1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas 2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer 3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. mRNA Cancer Vaccines And Therapeutics Market Characteristics

3. mRNA Cancer Vaccines And Therapeutics Market Trends And Strategies

4. mRNA Cancer Vaccines And Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global mRNA Cancer Vaccines And Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global mRNA Cancer Vaccines And Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global mRNA Cancer Vaccines And Therapeutics Market Growth Rate Analysis

5.4. Global mRNA Cancer Vaccines And Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global mRNA Cancer Vaccines And Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global mRNA Cancer Vaccines And Therapeutics Total Addressable Market (TAM)

6. mRNA Cancer Vaccines And Therapeutics Market Segmentation

6.1. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adeno Carcinomas

Mucinous Carcinomas

Adenosquamous Carcinomas

6.2. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infectious Disease

Cancer

Other Applications

6.3. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Ambulatory Surgical Centers

Research Institutes

Other End Users

6.4. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adeno Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lung Adenocarcinomas

Colon Adenocarcinomas

Prostate Adenocarcinomas

6.5. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Mucinous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mucinous Ovarian Cancer

Mucinous Breast Cancer

Mucinous Colorectal Cancer

6.6. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adenosquamous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pancreatic Adenosquamous Carcinoma

Cervical Adenosquamous Carcinoma

Esophageal Adenosquamous Carcinoma

7. mRNA Cancer Vaccines And Therapeutics Market Regional And Country Analysis

7.1. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market

8.1. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China mRNA Cancer Vaccines And Therapeutics Market

9.1. China mRNA Cancer Vaccines And Therapeutics Market Overview

9.2. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India mRNA Cancer Vaccines And Therapeutics Market

10.1. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan mRNA Cancer Vaccines And Therapeutics Market

11.1. Japan mRNA Cancer Vaccines And Therapeutics Market Overview

11.2. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia mRNA Cancer Vaccines And Therapeutics Market

12.1. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia mRNA Cancer Vaccines And Therapeutics Market

13.1. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea mRNA Cancer Vaccines And Therapeutics Market

14.1. South Korea mRNA Cancer Vaccines And Therapeutics Market Overview

14.2. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe mRNA Cancer Vaccines And Therapeutics Market

15.1. Western Europe mRNA Cancer Vaccines And Therapeutics Market Overview

15.2. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK mRNA Cancer Vaccines And Therapeutics Market

16.1. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany mRNA Cancer Vaccines And Therapeutics Market

17.1. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France mRNA Cancer Vaccines And Therapeutics Market

18.1. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy mRNA Cancer Vaccines And Therapeutics Market

19.1. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain mRNA Cancer Vaccines And Therapeutics Market

20.1. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market

21.1. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market Overview

21.2. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia mRNA Cancer Vaccines And Therapeutics Market

22.1. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America mRNA Cancer Vaccines And Therapeutics Market

23.1. North America mRNA Cancer Vaccines And Therapeutics Market Overview

23.2. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA mRNA Cancer Vaccines And Therapeutics Market

24.1. USA mRNA Cancer Vaccines And Therapeutics Market Overview

24.2. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada mRNA Cancer Vaccines And Therapeutics Market

25.1. Canada mRNA Cancer Vaccines And Therapeutics Market Overview

25.2. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America mRNA Cancer Vaccines And Therapeutics Market

26.1. South America mRNA Cancer Vaccines And Therapeutics Market Overview

26.2. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil mRNA Cancer Vaccines And Therapeutics Market

27.1. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East mRNA Cancer Vaccines And Therapeutics Market

28.1. Middle East mRNA Cancer Vaccines And Therapeutics Market Overview

28.2. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa mRNA Cancer Vaccines And Therapeutics Market

29.1. Africa mRNA Cancer Vaccines And Therapeutics Market Overview

29.2. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape And Company Profiles

30.1. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape

30.2. mRNA Cancer Vaccines And Therapeutics Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis SA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi AG Overview, Products and Services, Strategy and Financial Analysis

31. mRNA Cancer Vaccines And Therapeutics Market Other Major And Innovative Companies

31.1. AstraZeneca Plc

31.2. GlaxoSmithKline Plc

31.3. Hoffmann-La Roche AG

31.4. Eli Lilly and Company

31.5. Moderna Therapeutics Inc.

31.6. BioNTech SE

31.7. Regeneron Pharmaceuticals Inc.

31.8. Catalent Inc.

31.9. Sarepta Therapeutics Inc.

31.10. Arcturus Therapeutics Holdings Inc.

31.11. Genentech Inc.

31.12. Immatics Biotechnologies GmbH

31.13. CureVac N.V.

31.14. Anima Biotech

31.15. Argos Therapeutics Inc.

32. Global mRNA Cancer Vaccines And Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The mRNA Cancer Vaccines And Therapeutics Market

34. Recent Developments In The mRNA Cancer Vaccines And Therapeutics Market

35. mRNA Cancer Vaccines And Therapeutics Market High Potential Countries, Segments and Strategies

35.1 mRNA Cancer Vaccines And Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 mRNA Cancer Vaccines And Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 mRNA Cancer Vaccines And Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adeno Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Mucinous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adenosquamous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Pfizer Inc. Financial Performance

Table 78: Merck & Co Inc. Financial Performance

Table 79: Bayer AG Financial Performance

Table 80: Novartis SA Financial Performance

Table 81: Sanofi AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adeno Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Mucinous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adenosquamous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Pfizer Inc. Financial Performance

Figure 78: Merck & Co Inc. Financial Performance

Figure 79: Bayer AG Financial Performance

Figure 80: Novartis SA Financial Performance

Figure 81: Sanofi AG Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

Active Data Warehousing (ADW) Global Market Report 2025 – By Deployment Mode (Cloud-Based, On-Premises), By Enterprise Size (Large Enterprise, Small And Medium-Sized Enterprise), By Industry Vertical (Banking, Financial Services And Insurance (BFSI), Healthcare, Manufacturing, Information Technology (IT) And telecommunication, Government And public sector, Retail, Media And entertainment, Other Industry Verticals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer biologics Global Market Report 2025 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Skin Cancer Drugs Global Market Report 2025 – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents & Other Drugs), By End Users (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pancreatic Cancer Drugs Global Market Report 2025 – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Hospital Pharmacies, Retail Pharmacies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Breast Cancer Drugs Global Market Report 2025 – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer During Pregnancy, Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By End User (Ambulatory, Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bladder Cancer Drugs Global Market Report 2025 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the mRNA Cancer Vaccines And Therapeutics market?

How will the mRNA Cancer Vaccines And Therapeutics market drivers and restraints affect the market dynamics? What forces will shape the mRNA Cancer Vaccines And Therapeutics industry going forward?

The mRNA Cancer Vaccines And Therapeutics market major growth driver - Surge In Cancer Prevalence Boosts mRNA Vaccine And Therapeutics Market Growth. For further insights on the mRNA Cancer Vaccines And Therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the mRNA Cancer Vaccines And Therapeutics market?

The mRNA Cancer Vaccines And Therapeutics market size has grown strongly in recent years. The mRNA cancer vaccines and therapeutics market size has grown rapidly in recent years. It will grow from $61.52 billion in 2024 to $71.85 billion in 2025 at a compound annual growth rate (CAGR) of 16.8%. The growth in the historic period can be attributed to the shifting lifestyles, the funding support, the favorable regulatory environment, the well-established healthcare infrastructure, and increasing pipeline development. The mRNA cancer vaccines and therapeutics market size is expected to see rapid growth in the next few years. It will grow to $131.99 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to promising clinical trial results, growing awareness and acceptance of mRNA technology, unmet medical needs in cancer treatment, potential for improved patient outcomes and potential for off-the-shelf availability. Major trends in the forecast period include expansion into new therapeutic areas, personalized medicine approach, advancements in mRNA delivery systems, multivalent mRNA Vaccines and artificial intelligence and machine learning in mRNA design. For further insights on the mRNA Cancer Vaccines And Therapeutics market, request a sample here

How is the mRNA Cancer Vaccines And Therapeutics market segmented?

The mRNA cancer vaccines and therapeutics market covered in this report is segmented –
1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users
Subsegments:
1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas
2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer
3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma For further insights on the mRNA Cancer Vaccines And Therapeutics market, request a sample here

Which region has the largest share of the mRNA Cancer Vaccines And Therapeutics market? What are the other regions covered in the report?

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the mRNA Cancer Vaccines And Therapeutics market, request a sample here.

Who are the major players in the mRNA Cancer Vaccines And Therapeutics market?

What are the key trends in the mRNA Cancer Vaccines And Therapeutics market?

Major trends in the mRNA Cancer Vaccines And Therapeutics market include FDA Approves WGc-043, Boosting Innovations In mRNA Cancer Vaccines And Therapies. For further insights on the mRNA Cancer Vaccines And Therapeutics market, request a sample here.

What are the major opportunities in the mRNA Cancer Vaccines And Therapeutics market? What are the strategies for the mRNA Cancer Vaccines And Therapeutics market?

For detailed insights on the major opportunities and strategies in the mRNA Cancer Vaccines And Therapeutics market, request a sample here.

How does the mRNA Cancer Vaccines And Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on mRNA Cancer Vaccines And Therapeutics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the mRNA Cancer Vaccines And Therapeutics industry?

For detailed insights on the mergers and acquisitions in the mRNA Cancer Vaccines And Therapeutics industry, request a sample here.

What are the key dynamics influencing the mRNA Cancer Vaccines And Therapeutics market growth? SWOT analysis of the mRNA Cancer Vaccines And Therapeutics market.

For detailed insights on the key dynamics influencing the mRNA Cancer Vaccines And Therapeutics market growth and SWOT analysis of the mRNA Cancer Vaccines And Therapeutics industry, request a sample here.